Monica Neagu received a BSc and MSc in biochemistry from the Faculty of Biochemistry, University of Bucharest in 1984 and 1985, respectively. She obtained her PhD from the Romanian Academy of Science in 1996. She is head of the Immunology Laboratory, Victor Babeş National Institute of Pathology, Bucharest, Habilitation in Immunology, Doctoral School of the Faculty of Biology, University of Bucharest, a senior researcher at the Pathology Department, Colentina Clinical Hospital, president of the Romanian Society of Immunology, and member of the World Academy of Sciences. She has an autoimmunity specialization at Sandoz Pharma Ltd., Basel. From 2010 to 2013, she was a full member of the Commission for Advanced Therapies—EMEA. Her fields of interest are immuno-oncology, biomarkers, proteomic array approaches, animal models for skin carcinogenesis, wound healing, regeneration, toxicology, and biocompatibility. She is a co-inventor on several patents in dermato-oncology, biomarker panels, and tumor cell clones.